COSMA Dementia App entry into Scandinavian Market

点击翻译按钮获取中文摘要

There is an increasing proportion of the global population with memory problems, depression, space-time disorientation or decreased logical reasoning with aging. These onset symptoms may lead to early-stage neurodegenerative disorders e.g. dementia. As these conditions progress, the brainwave activities decline.Present drug treatments come with severe side-effects, and non-drug treatments i.e. brain training apps are not patient specific and are not validated through clinical trials.We aim to address this global issue by developing a unique-personalised, clinically validated cognitive app which improves a patient's cognitive brain function through application of therapeutic games and machine learning.Benefits: (1) non-invasive; (2) improved mental ability; (3) global market; (5) ensures patient independence; (6) reduced stress upon healthcare systems; and (6) will strengthen UK as leader in neurological disorder research.